SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 235 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,000 | -7.1% | 472 | +3.1% | 0.00% | – |
| Q2 2023 | $14,000 | -22.2% | 458 | -6.7% | 0.00% | – |
| Q1 2023 | $18,000 | 0.0% | 491 | -1.4% | 0.00% | – |
| Q4 2022 | $18,000 | -57.1% | 498 | -60.3% | 0.00% | – |
| Q3 2022 | $42,000 | +61.5% | 1,253 | +41.6% | 0.00% | – |
| Q2 2022 | $26,000 | +100.0% | 885 | +112.7% | 0.00% | – |
| Q1 2022 | $13,000 | -98.9% | 416 | -99.1% | 0.00% | -100.0% |
| Q4 2020 | $1,189,000 | +56.4% | 47,258 | +29.5% | 0.01% | +25.0% |
| Q3 2020 | $760,000 | -3.6% | 36,479 | +27.1% | 0.00% | 0.0% |
| Q3 2019 | $788,000 | +163.5% | 28,691 | +217.3% | 0.00% | +100.0% |
| Q2 2019 | $299,000 | – | 9,041 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 921,962 | $33,402,683 | 5.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 423,500 | $15,326,465 | 4.28% |
| ARMISTICE CAPITAL, LLC | 4,350,000 | $157,600,500 | 2.27% |
| S&T BANK/PA | 223,775 | $8,107 | 1.46% |
| Aristotle Capital Boston, LLC | 1,155,149 | $41,851,071 | 1.29% |
| Tributary Capital Management, LLC | 353,671 | $12,813,500 | 1.19% |
| Bridge City Capital, LLC | 62,790 | $2,274,882 | 1.14% |
| RICE HALL JAMES & ASSOCIATES, LLC | 551,285 | $19,973,056 | 1.14% |
| Intrinsic Edge Capital Management LLC | 289,704 | $10,495,976 | 1.05% |
| Parkman Healthcare Partners LLC | 131,878 | $4,777,940 | 1.04% |